The clinical characteristics of patients with congenital nephrotic syndrome secondary to NPHS1 mutation: Is nephrectomy still a therapeutic option for selected cases?
- PMID: 40266336
- PMCID: PMC12187890
- DOI: 10.1007/s00467-025-06774-6
The clinical characteristics of patients with congenital nephrotic syndrome secondary to NPHS1 mutation: Is nephrectomy still a therapeutic option for selected cases?
Erratum in
-
Publisher Correction: The clinical characteristics of patients with congenital nephrotic syndrome secondary to NPHS1 mutation: Is nephrectomy still a therapeutic option for selected cases?Pediatr Nephrol. 2025 Aug;40(8):2715. doi: 10.1007/s00467-025-06806-1. Pediatr Nephrol. 2025. PMID: 40346439 Free PMC article. No abstract available.
Abstract
Background: Managing congenital nephrotic syndrome (CNS) remains a clinical challenge. While albumin infusions and nephrectomy have been long-standing treatments, a conservative approach is increasingly favored. This study aimed to compare clinical outcomes between nephrectomy (Nx) and non-Nx in patients with bi-allelic NPHS1 mutations.
Methods: This retrospective cohort study included 29 pediatric CNS patients (15 female, 14 male) with confirmed NPHS1 mutations. Clinical parameters including albumin infusion requirements, infections, hospitalizations, growth, and survival rates were analyzed in the Nx and non-Nx groups.
Results: The median age at the time CNS was diagnosed was 29 days (IQR: 11-62 days). In all, 24 patients (82.8%) had homozygous NPHS1 mutations and 5 (17.2%) had compound heterozygous NPHS1 mutations. None of the patients had Fin-major mutation (i.e., p. Leu41 Aspfs*50). Unilateral/bilateral nephrectomy was performed in 16 patients. At 12 months post-nephrectomy the number of albumin infusions required, infections, and hospitalizations decreased significantly in the Nx group, as compared to the pre-nephrectomy period (p = 0.001, p = 0.027, and p = 0.004, respectively). Among the 13 (44.8%) patients in the non-Nx group, at 12 months after CNS was diagnosed the number of serum albumin infusions required significantly decreased (p = 0.007); however, the number of infections and hospitalization did not differ significantly (p = 0.589 and p = 0.5, respectively). Receiver operating characteristic (ROC) analysis showed that requiring albumin infusions ≥ 14 days/month predicted the decision to perform nephrectomy with 68% accuracy (73% sensitivity and 62% specificity).
Conclusions: Nephrectomy reduces albumin infusions, infections, and hospitalizations, suggesting it may be a beneficial treatment for selected CNS patients with NPHS1 mutations.
Keywords: NPHS1 mutation; Congenital nephrotic syndrome; Nephrectomy; Nephrin.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: The study protocol was approved by the Hacettepe University Ethics Committee (2022/05–29) and was performed in accordance with the principles of the Declaration of Helsinki. Conflict of interest: The authors declare there are no conflicts of interest—financial or otherwise—related to the material presented herein.
Figures




References
-
- Holmberg C, Antikainen M, Rönnholm K, Ala Houhala M, Jalanko H (1995) Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 9:87–93 - PubMed
-
- Cameron JS (1987) The nephrotic syndrome and its complications. Am J Kidney Dis 10:157–171 - PubMed
-
- Coulthard MG (1989) Management of Finnish congenital nephrotic syndrome by unilateral nephrectomy. Pediatr Nephrol 3:451–453 - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources